Dr Reddy's Laboratories witnessed a fall in share price on Thursday after the drugmaker informed NSE that the US Food and Drug Administration (FDA) has made 13 observations relating to deviation from good manufacturing practices (GMP) at the company's cancer formulations facility at Duvvada in Visakhapatnam.

Shares of Dr Reddy'S Laboratories are trading at Rs 2,737.00, down Rs 114.4, or 4.01% at the Bombay Stock Exchange (BSE) on Thursday at 10:29 a.m.

The scrip has touched an intra-day high of Rs 2,800 and low of Rs 2,727. The total volume of shares traded at the BSE is 99,297.

Total volume of shares traded on the bourses today was higher by 79.46% to 1,057,736 compared with 22-day average volume of 589,403.